Connect with us

INDUSTRIAL HEMP

Lexaria Bioscience Corp (OTCMKTS:LXRP) Update On R&D Process

Published

on

With its better financial ability, Lexaria Bioscience Corp (OTCMKTS:LXRP) were able to report a $1 million budget for Research & Development using their patented DehydraTECH™ palatability and absorption improving know-how meant to establish long term value, considerably more than they have ever spent in the past.

The details

Lexaria Bioscience continue to run within that budget with strategies for a cannabidiol-infused topical cream moving in vitro absorption test planned for January – February; a nicotine-infused oral solution in absorption and vivo tolerability test also scheduled during same time; in-house formulation trials for other formulation variants and enhancements continuing on a current basis; and formulation testing and optimization with potential corporate customers also continuing on an underway basis.

In addition, Lexaria is pursuing a number of IP enhancement processes also within their R&D budget as they continually endeavor to expand and broaden their IP portfolio. As results from existing phase experiments are made they can use their increased knowledge to re-assess and enter more developed stages of experimentation.

Lexaria is progressing into next phase experimentation with its 2017-announced association with Canada’s National Research Council. Development here has been computed to date and they project it to continue in this year.

They reported a thrilling set of tests to advance in association with the University of British Columbia and were set to proceed with the release of those tests in December, having lately completed the quality control testing and manufacturing of all three of the needed test articles. Unfortunately, University of British Columbia has revised their guidelines for these types of tests which are presently on hold, but, they are working to either get those tests introduced considerably as intended, or make other preparations to perform so elsewhere.

Lexaria is content understanding they have adequate funds in-hand to close their expected R&D assignments and budget throughout 2018.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement